News

All | 2023 | 2022 | 2021 | 2020

Welcome to ULACNet Update, where we share programmatic and research updates for the US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet)! This newsletter is available in 4 languages:... Read More

POSTED: 01/30/2023
SOURCE: DCP News

The Oportunidad Navigators

The Cancer Prevention Fellowship Program (CPFP) at the National Cancer Institute is the flagship multidisciplinary postdoctoral training program in cancer prevention. This intramural program has been in existence at the NCI... Read More

POSTED: 01/18/2023
SOURCE: DCP News

Chemopreventive Agent Development Research Group, Division of Cancer Prevention The National Cancer Institute (NCI), Division of Cancer Prevention (DCP), is seeking a Program Director to manage the formulation, production... Read More

POSTED: 01/12/2023
SOURCE: DCP News

The National Cancer Institute’s (NCI’s) Board of Scientific Advisors (BSA) recently approved two new concept proposals aimed at expanding potential prevention interventions. One will strengthen research in the nascent field... Read More

POSTED: 01/10/2023
SOURCE: Cancer Prevention Science Blog

Cancer Immunoprevention Network (CIP-Net): Pathways, Targets, Immune Cells, Vaccines, Agents

A JNCI monograph on Engaging Older Adults in Cancer Clinical Trials Conducted in the National Cancer Institute Clinical Trials Network is available now. The articles, developed through working groups formed for an NCI... Read More

POSTED: 12/21/2022
SOURCE: DCP News

Cover of the Jounal of the National Cancer Institute Monograph, 2022, Number 60..

CP-CTNet Newsletter - December 2022

Staff Highlight, DMACC Updates (Data Management and Reporting Unit, CP-CTNET DMACC Public Website and Portal Gateway Update, Clinical Trials Auditing Unit, Administrative and Coordinating Unit), In Memoriam, and Research... Read More

POSTED: 12/16/2022
SOURCE: CP-CTNet DMACC Website

Cover of the December 2022 CP-CTNet Newsletter

This month’s Research Highlights focuses on provider and patient beliefs about mammogram screening frequency, and separately, provider barriers to engaging in shared decision-making with high-risk patients about the use of... Read More

POSTED: 11/28/2022
SOURCE: Cancer Prevention Science Blog

An image of a medical technician reviewing a mammogram seen on computer screen.

The National Cancer Institute Division of Cancer Prevention has released three Funding Opportunity Announcements to accept applications to create the Cancer Screening Research Network (CSRN).  The CSRN will conduct rigorous... Read More

POSTED: 11/21/2022
SOURCE: DCP News

CSRN Funding Announcements Published. ACCrual, Enrollment, and Screening Sites (ACCESS) Hub (UG1), Coordinating and Communication Center (UG1), Statistics and Data Management Center (UG1)

Cervical cancer can be prevented by human papillomavirus (HPV) vaccination and by screening for and treating precancerous lesions. Yet, millions of women globally remain at high-risk for developing cervical cancer. This is... Read More

POSTED: 11/14/2022
SOURCE: Cancer Prevention Science Blog

CASCADE's 4 Focus Areas

Cancer Biomarkers Research Group, Division of Cancer Prevention The National Cancer Institute (NCI) is seeking a Program Director to lead an innovative portfolio of research focused on biomarkers for cancer early detection... Read More

POSTED: 11/10/2022
SOURCE: DCP News

Office of the Director, Division of Cancer Prevention The National Cancer Institute (NCI) is seeking a Program Director to lead an innovative portfolio of research focused on symptom management, palliative care, and quality... Read More

POSTED: 11/02/2022
SOURCE: DCP News

This issue of Research Highlights focuses on how cells progress to become breast cancer, and separately, how breast cancer may spread. Understanding these transitional moments can help researchers keep invasive cancer from... Read More

POSTED: 10/24/2022
SOURCE: Cancer Prevention Science Blog

A breast tumor and its microenvironment.

CP-CTNet Newsletter - September 2022

Featured Article: CP-CTNet Cross Network Study: Lynch Syndrome.  Inherited susceptibility to cancer involves defects in genes that normally function to suppress the formation of tumors. One such syndrome was recognized by... Read More

POSTED: 09/30/2022
SOURCE: CP-CTNet DMACC Website

Screen capture of the CP-CTNet September 2022 Newsletter

More than half of cancer survivors who were treated with chemotherapy for the four most common types of cancer experienced clinically significant hearing loss and tinnitus after treatment, according to new research. The... Read More

POSTED: 09/27/2022
SOURCE: Cancer Prevention Science Blog

In this study, more than 50% of cancer survivors treated with platinum- or taxane-containing chemotherapies were found to have significant hearing loss and tinnitus after treatment.

Welcome to ULACNet Update, where we share programmatic and research updates for the US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet)! English On this page As we... Read More

POSTED: 09/23/2022
SOURCE: DCP News

ULACNet Update

Recruitment has begun for a clinical study that investigators hope will move “liquid biopsy” technology closer to its still-distant goal: a single blood test for the early detection of cancer. Collectively known as multi-... Read More

POSTED: 09/15/2022
SOURCE: Cancer Prevention Science Blog

An image of a research holding a blood sample in a test tube.

Research Highlights are a new type of blog for Cancer Prevention Science, where recent publications are highlighted rather than a traditional news story. This month’s blog post highlights how a cruciferous vegetable extract... Read More

POSTED: 08/24/2022
SOURCE: Cancer Prevention Science Blog

An image of cruciferous vegetables.

In 2012, Patricia Ganz, M.D., saw a 39-year-old cancer survivor for a consultation who had a long-term history of anxiety during medical visits. The woman had been diagnosed with Hodgkin lymphoma when she was 23 years old.... Read More

POSTED: 08/10/2022
SOURCE: Cancer Prevention Science Blog

Cover of Cancer Care for the Whole Patient: Meeting Psychosocial Health Needs

CP-CTNet Newsletter - July 2022

Welcome to the CP-CTNet Newsletter where we share programmatic and research updates for the Cancer Prevention Clinical Trials Network (CP-CTNet). Read More

POSTED: 07/22/2022
SOURCE: CP-CTNet DMACC Website

Cover of the July 2022 issue of the CP-CTNet Newsletter

Unlike many other cancers, the incidence and death rates for uterine cancer are rising. Rates of new uterine cancer cases have risen 0.6% per year from 2010-2019, and death rates have risen an average of 1.7% per year for... Read More

POSTED: 06/28/2022
SOURCE: Cancer Prevention Science Blog

An example of a nonendometrioid cancer.

‘The complexities are staggering.’ U.S. plans huge trial of blood tests for multiple cancers

National Cancer Institute prevention chief discusses steps toward largest U.S. cancer screening trial ever Read More

POSTED: 06/22/2022
SOURCE: Science Magazine

A gloved hand lifting a test tube of a blood sample from a rack.

Key Messages Although aspirin use has been studied for decades, there are still many gaps in our understanding its role in cancer prevention. Risk-benefit analyses should be conducted to ensure that the right patients are... Read More

POSTED: 06/15/2022
SOURCE: DCP News

In the era of personalized medicine, prevention and screening for breast cancer are evolving toward new approaches that assess each woman’s risk and lifestyle factors. All women do not carry the same risk for the same type... Read More

POSTED: 05/06/2022
SOURCE: Cancer Prevention Science Blog

Established Risk Factors for Developing Female Breast Cancer

Welcome to ULACNet Update, where we will share programmatic and research updates for the US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet)! English On this page The... Read More

POSTED: 04/28/2022
SOURCE: DCP News

ULACNet-301 participant receiving first study vaccine.

Screening for Many Cancers with One Test: Uncertainty Abounds

One of the exciting areas of cancer prevention research is the development of noninvasive tests that may have the potential to easily and accurately determine whether and where in the body a person has early-stage cancer.... Read More

POSTED: 04/21/2022
SOURCE: NCI Cancer Currents Blog

Illustration of biomarkers that are released by cancer cells or induced by their presence.

Pages